In 2019, it was reconfirmed that PTX3, as a natural FGF trap inhibitor, could significantly suppress melanoma tumor growth and liver metastasis, thus inhibiting the proliferation and migration of melanoma cells (108), making PTX3 a promising therapeutic target for melanoma patients. Here, PTX3 is linked to melanoma.